Guerbet Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GUERBET
GUERBET has five approved drugs.
There are four US patents protecting GUERBET drugs.
There are eighty-seven patent family members on GUERBET drugs in twenty-eight countries and thirteen supplementary protection certificates in eleven countries.
Summary for Guerbet
| International Patents: | 87 |
| US Patents: | 4 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-004 | Sep 21, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-003 | Sep 21, 2022 | RX | Yes | Yes | 12,064,487 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-003 | Sep 21, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-006 | Sep 21, 2022 | RX | Yes | Yes | 10,973,934 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-007 | Sep 21, 2022 | RX | Yes | Yes | 8,114,863 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | 4,954,348 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,014,986 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,554 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,553 | ⤷ Start Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,094,966 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Guerbet Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 3902800 | ⤷ Start Trial |
| South Korea | 101440761 | ⤷ Start Trial |
| Japan | 7071596 | ⤷ Start Trial |
| South Korea | 20210138134 | ⤷ Start Trial |
| South Korea | 20210041566 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Guerbet Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1931673 | 7/2024 | Austria | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: EU/1/23/1772 (MITTEILUNG) 20231208 |
| 1931673 | CA 2024 00011 | Denmark | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REG. NO/DATE: EU/1/23/1772 20231208 |
| 1931673 | C202430008 | Spain | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; NATIONAL AUTHORISATION NUMBER: EU/1/23/1772; DATE OF AUTHORISATION: 20231207; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/23/1772; DATE OF FIRST AUTHORISATION IN EEA: 20231207 |
| 1931673 | 122024000009 | Germany | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: EU/1/23/1772 20231207 |
| 1931673 | CR 2024 00011 | Denmark | ⤷ Start Trial | PRODUCT NAME: GADOPICLENOL; REG. NO/DATE: EU/1/23/1772 20231208 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
